| P50 | author | Meinrad Gawaz | Q89518767 |
| | Oliver Borst | Q117266809 |
| | Tobias Geisler | Q124254157 |
| | Sebastian Vogel | Q52654318 |
| | Madhumita Chatterjee | Q64858095 |
| | Peter Seizer | Q88872106 |
| P2093 | author name string | Andreas Mack | |
| | Florian Lang | |
| | Hans-Jörg Bühring | |
| | Iris Müller | |
| | Rüdiger V Sorg | |
| | Harald Langer | |
| | Katja Metzger | |
| | Susanne Schumann | |
| P2860 | cites work | Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways | Q95717860 |
| | Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction | Q24534652 |
| | Platelets in tissue repair: control of apoptosis and interactions with regenerative cells | Q26862152 |
| | An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials | Q26865152 |
| | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 |
| | Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator | Q28263346 |
| | High mobility group box 1 protein interacts with multiple Toll-like receptors | Q28280114 |
| | Mesenchymal stem cells in health and disease | Q29614296 |
| | Sterile inflammation: sensing and reacting to damage | Q29620014 |
| | Paracrine mechanisms in adult stem cell signaling and therapy | Q29620571 |
| | Transcoronary transplantation of progenitor cells after myocardial infarction | Q30824315 |
| | Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging | Q33193903 |
| | A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype | Q33570359 |
| | TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection | Q33769592 |
| | Cardiomyocytes can be generated from marrow stromal cells in vitro | Q33843659 |
| | CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model | Q34090214 |
| | Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 |
| | The inflammatory response in myocardial infarction | Q34463456 |
| | Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells | Q35011205 |
| | Production of hepatocyte growth factor during acute myocardial infarction | Q35375482 |
| | HMGB1 is a therapeutic target for sterile inflammation and infection | Q35953553 |
| | Healing after myocardial infarction | Q36071600 |
| | Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo | Q36238074 |
| | Platelets in inflammation and atherogenesis. | Q36328825 |
| | Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction | Q37294044 |
| | Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications | Q37850831 |
| | Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications | Q38648794 |
| | Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment | Q39208145 |
| | Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone | Q40390871 |
| | Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein | Q40609759 |
| | Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. | Q40761395 |
| | Platelet hyperreactivity and prognosis in survivors of myocardial infarction | Q41229453 |
| | Toll-like receptors and their ligands control mesenchymal stem cell functions | Q42502648 |
| | Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses | Q42575579 |
| | Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication | Q43252660 |
| | Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. | Q45865712 |
| | Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro | Q46070845 |
| | Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling | Q46264543 |
| | Effects of HMGB1 on ischemia-reperfusion injury in the rat heart | Q46520353 |
| | Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy | Q46685771 |
| | A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function | Q47724235 |
| | Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells | Q47820046 |
| | Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. | Q51116689 |
| | Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. | Q51638429 |
| | The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling. | Q54294874 |
| | Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. | Q54473910 |
| | Adherent Platelets Recruit and Induce Differentiation of Murine Embryonic Endothelial Progenitor Cells to Mature Endothelial Cells In Vitro | Q58807988 |
| | High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart | Q63384080 |
| | Platelet activation in unstable coronary disease | Q68903080 |
| | Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation | Q73387665 |
| | Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model | Q73418656 |
| | Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells | Q77319716 |
| | Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells | Q80217129 |
| | Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction | Q80246358 |
| | Mesenchymal stem cells for myocardial infarction: promises and pitfalls | Q80357437 |
| | High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice | Q81466842 |
| | The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy | Q83717385 |
| | Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation | Q84029874 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| | apoptotic process | Q14599311 |
| | toll-like receptor | Q408004 |
| P304 | page(s) | 11068-11082 | |
| P577 | publication date | 2014-02-24 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET | |
| P478 | volume | 289 | |